Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

Fig. 2

Progression-free survival (PFS) of patients based on inflammation-based cumulative prognostic score (ICPS) system. a The ICPS system classified patients into four PFS risk groups (ICPS = 0, ICPS = 1, ICPS = 2 and ICPS = 3); (b) The ICPS system classified patients into three PFS risk groups (ICPS = 0–1, ICPS = 2 and ICPS = 3)

Back to article page